While this study identified a clear role for sCD163 in stroke immunopathology in terms of its end-action, our experiments did not look to identify the soluble factors present in peripheral circulation following stroke which are responsible for triggering the shedding of CD163 from monocytes. Here, CD163 is linked to stroke disorder.